Prognostic Value of Discharge Hemoglobin Level in Patients Hospitalized for Acute Heart Failure

Sánchez-Torrijos, Jorge; Gudín-Uriel, Margarita; Nadal-Barangé, Mercedes; Jacas-Osborn, Victoria; Trigo-Bautista, Alberto; Giménez-Alcalá, Mónica; Payá-Serrano, Rafael; Ridocci-Soriano, Francisco

doi:10.1016/s1885-5857(07)60084-x

Cited by 4 publications

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These data suggest that a disease-specific definition of anemia in HF populations might consist of cutoff values higher than those proposed by the WHO and NKF. In some studies, an interesting ''U''-shaped relationship between hemoglobin levels and mortality risk has been reported, with lowest mortality risk in the normal hemoglobin range of 13-16 g/dl, and higher mortality risk associated with values both lower and higher than this reference range [8,26,46,47]. In a large cohort study of 59,772 members of Kaiser Permanente in Northern California diagnosed with chronic HF, hemoglobin levels \13 or [17 g/dl were associated with greater risk of all-cause mortality and heart failure hospitalization when compared with a reference group of patients with hemoglobin levels of 13.0-13.9 g/dl.…”

Section: Impact Of Anemia On Clinical Outcomes In Hfmentioning

confidence: 99%

The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes

Tang

Katz

2008

Heart Fail Rev

View full text Add to dashboard Cite

This review article summarizes the current medical literature reporting on the prevalence and prognostic significance of anemia in patients with heart failure. Almost all currently available data indicate that anemia is common in heart failure populations, with the majority of studies indicating prevalence >20%. Anemia appears to be more highly prevalent in patients with advanced age, with more severe limitations in functional capacity, and with greater severity of co-morbid chronic kidney disease. In most reported studies anemia is an independent predictor of increased mortality risk and increased risk of hospitalization for heart failure. These data provide the rationale for interventional treatment trials to determine if anemia is in the causal pathway for disease progression and increased mortality risk in HF patients.

show abstract

Section: Impact Of Anemia On Clinical Outcomes In Hfmentioning

confidence: 99%